A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

NCT06606340 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: Eteplirsen
DRUG: Golodirsen
DRUG: Casimersen

Sponsor

Sarepta Therapeutics, Inc.